Medical facilities are attractive targets for cyber criminals because of their technological dependence and sensitive data ..read more

Investigators question the usefulness of TKI-IO combinations in poor-risk disease ..read more

Rate of CIN reduced with inorganic nitrate among patients undergoing coronary angiography ..read more

Minimally invasive transurethral ultrasound ablation provides disease control without side effects ..read more

Nogapendekin alfa inbackicept-pmin is an interleukin-15 receptor agonist ..read more

Researchers conducted a systematic review and meta-analysis to assess the relationship between statin use and new-onset diabetes risk ..read more

The Food and Drug Administration (FDA) has granted Fast Track designation to enibarcimab for the treatment of septic shock. Enibarcimab (formerly adrecizumab) is a first-in-class non-neutralizing monoclonal antibody that binds to adrenomedullin (ADM), a vasoprotective hormone. It is believed that modulating the ADM pathway may improve outcomes in patients with septic shock. The Fast Track ..read more

Anti-TNF therapy was not associated with the risk for eGFR decline among patients using corticosteroids ..read more

Up to 40% of patients hospitalized with urinary tract infection unnecessarily receive extended-spectrum antibiotics ..read more

Antihypertensive medication initiation also linked to higher risk for severe falls requiring hospitalization, ED visits ..read more